Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 99

1.

Don't be fooled by the fat: A rare case of renal cell carcinoma with intratumoural fat.

Morris H, March B, Delprado W, McLeod N.

Urol Case Rep. 2019 Dec 27;30:101112. doi: 10.1016/j.eucr.2019.101112. eCollection 2020 May.

2.

Don't be fooled by the fat: A rare case of renal cell carcinoma with intratumoural fat.

Morris H, March B, Delprado W, McLeod N.

Urol Case Rep. 2020 Jan 9;30:101116. doi: 10.1016/j.eucr.2020.101116. eCollection 2020 May.

3.

The Magnetic Resonance Imaging in Active Surveillance "MRIAS" Trial: Use of Baseline Multiparametric Magnetic Resonance Imaging and Saturation Biopsy to Reduce the Frequency of Surveillance Prostate Biopsies.

Amin A, Scheltema MJ, Shnier R, Blazevski A, Moses D, Cusick T, Siriwardena A, Yuen B, van Leeuwen PJ, Haynes AM, Matthews J, Brenner P, O'Neill G, Yuen C, Delprado W, Stricker P, Thompson J.

J Urol. 2019 Dec 11:101097JU0000000000000693. doi: 10.1097/JU.0000000000000693. [Epub ahead of print]

PMID:
31825297
4.

Pathological Characteristics of Prostate Cancer Occurring in Younger Men: A Retrospective Study of Prostatectomy Patients.

Macneil J, Maclean F, Delprado W.

Urology. 2019 Dec;134:163-167. doi: 10.1016/j.urology.2019.08.048. Epub 2019 Sep 18.

PMID:
31541648
5.

p53 nuclear accumulation as an early indicator of lethal prostate cancer.

Quinn DI, Stricker PD, Kench JG, Grogan J, Haynes AM, Henshall SM, Grygiel JJ, Delprado W, Turner JJ, Horvath LG, Mahon KL.

Br J Cancer. 2019 Oct;121(7):578-583. doi: 10.1038/s41416-019-0549-8. Epub 2019 Aug 14.

PMID:
31409910
6.

Diagnostic accuracy of 68 Ga-prostate-specific membrane antigen (PSMA) positron-emission tomography (PET) and multiparametric (mp)MRI to detect intermediate-grade intra-prostatic prostate cancer using whole-mount pathology: impact of the addition of 68 Ga-PSMA PET to mpMRI.

Scheltema MJ, Chang JI, Stricker PD, van Leeuwen PJ, Nguyen QA, Ho B, Delprado W, Lee J, Thompson JE, Cusick T, Spriensma AS, Siriwardana AR, Yuen C, Kooner R, Hruby G, O'Neill G, Emmett L.

BJU Int. 2019 Nov;124 Suppl 1:42-49. doi: 10.1111/bju.14794. Epub 2019 Jul 9.

7.

Oncological and Quality-of-life Outcomes Following Focal Irreversible Electroporation as Primary Treatment for Localised Prostate Cancer: A Biopsy-monitored Prospective Cohort.

Blazevski A, Scheltema MJ, Yuen B, Masand N, Nguyen TV, Delprado W, Shnier R, Haynes AM, Cusick T, Thompson J, Stricker P.

Eur Urol Oncol. 2019 May 16. pii: S2588-9311(19)30057-4. doi: 10.1016/j.euo.2019.04.008. [Epub ahead of print]

PMID:
31103721
8.

Reduced sensitivity of multiparametric MRI for clinically significant prostate cancer in men under the age of 50.

Gielchinsky I, Scheltema MJ, Cusick T, Chang J, Shnier R, Moses D, Delprado W, Nguyen Q, Yuen C, Haynes AM, Stricker PD.

Res Rep Urol. 2018 Oct 4;10:145-150. doi: 10.2147/RRU.S169017. eCollection 2018.

9.

Prostate cancer in 432 men aged <50 years in the prostate-specific antigen era: a new outlook.

Gielchinsky I, Chang J, Cusick T, Delprado W, Nguyen Q, Yuen C, Savdie R, Böhm M, Haynes AM, Scheltema MJ, Stricker PD.

BJU Int. 2018 Nov;122 Suppl 5:35-41. doi: 10.1111/bju.14586. Epub 2018 Nov 8.

10.

An analysis of a multiple biomarker panel to better predict prostate cancer metastasis after radical prostatectomy.

Zhang AY, Chiam K, Haupt Y, Fox S, Birch S, Tilley W, Butler LM, Knudsen K, Comstock C, Rasiah K, Grogan J, Mahon KL, Bianco-Miotto T, Ricciardelli C, Böhm M, Henshall S, Delprado W, Stricker P, Horvath LG, Kench JG.

Int J Cancer. 2019 Mar 1;144(5):1151-1159. doi: 10.1002/ijc.31906. Epub 2018 Dec 4.

11.

Identifying the morphologic basis for radiomic features in distinguishing different Gleason grades of prostate cancer on MRI: Preliminary findings.

Penzias G, Singanamalli A, Elliott R, Gollamudi J, Shih N, Feldman M, Stricker PD, Delprado W, Tiwari S, Böhm M, Haynes AM, Ponsky L, Fu P, Tiwari P, Viswanath S, Madabhushi A.

PLoS One. 2018 Aug 31;13(8):e0200730. doi: 10.1371/journal.pone.0200730. eCollection 2018.

12.

Radiomic features on MRI enable risk categorization of prostate cancer patients on active surveillance: Preliminary findings.

Algohary A, Viswanath S, Shiradkar R, Ghose S, Pahwa S, Moses D, Jambor I, Shnier R, Böhm M, Haynes AM, Brenner P, Delprado W, Thompson J, Pulbrock M, Purysko AS, Verma S, Ponsky L, Stricker P, Madabhushi A.

J Magn Reson Imaging. 2018 Feb 22. doi: 10.1002/jmri.25983. [Epub ahead of print]

13.

Preliminary Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging to Detect Residual Prostate Cancer Following Focal Therapy with Irreversible Electroporation.

Scheltema MJ, Chang JI, van den Bos W, Böhm M, Delprado W, Gielchinsky I, de Reijke TM, de la Rosette JJ, Siriwardana AR, Shnier R, Stricker PD.

Eur Urol Focus. 2019 Jul;5(4):585-591. doi: 10.1016/j.euf.2017.10.007.

PMID:
29102671
14.

Feasibility and safety of focal irreversible electroporation as salvage treatment for localized radio-recurrent prostate cancer.

Scheltema MJ, van den Bos W, Siriwardana AR, Kalsbeek AMF, Thompson JE, Ting F, Böhm M, Haynes AM, Shnier R, Delprado W, Stricker PD.

BJU Int. 2017 Nov;120 Suppl 3:51-58. doi: 10.1111/bju.13991. Epub 2017 Sep 19.

15.

Focal irreversible electroporation as primary treatment for localized prostate cancer.

van den Bos W, Scheltema MJ, Siriwardana AR, Kalsbeek AMF, Thompson JE, Ting F, Böhm M, Haynes AM, Shnier R, Delprado W, Stricker PD.

BJU Int. 2018 May;121(5):716-724. doi: 10.1111/bju.13983. Epub 2017 Sep 4.

16.

Initial multicentre experience of 68 gallium-PSMA PET/CT guided robot-assisted salvage lymphadenectomy: acceptable safety profile but oncological benefit appears limited.

Siriwardana A, Thompson J, van Leeuwen PJ, Doig S, Kalsbeek A, Emmett L, Delprado W, Wong D, Samaratunga H, Haynes AM, Coughlin G, Stricker P.

BJU Int. 2017 Nov;120(5):673-681. doi: 10.1111/bju.13919. Epub 2017 Jun 20.

17.

Population-based study of grade progression in patients who harboured Gleason 3 + 3.

Sampurno F, Earnest A, Millar J, Frydenberg M, Murphy D, Delprado W, Evans S.

World J Urol. 2017 Nov;35(11):1689-1699. doi: 10.1007/s00345-017-2047-z. Epub 2017 May 12.

PMID:
28500489
18.

Predictive value of the 2014 International Society of Urological Pathology grading system for prostate cancer in patients undergoing radical prostatectomy with long-term follow-up.

Grogan J, Gupta R, Mahon KL, Stricker PD, Haynes AM, Delprado W, Turner J, Horvath LG, Kench JG.

BJU Int. 2017 Nov;120(5):651-658. doi: 10.1111/bju.13857. Epub 2017 Apr 30.

19.

A multiparametric magnetic resonance imaging-based risk model to determine the risk of significant prostate cancer prior to biopsy.

van Leeuwen PJ, Hayen A, Thompson JE, Moses D, Shnier R, Böhm M, Abuodha M, Haynes AM, Ting F, Barentsz J, Roobol M, Vass J, Rasiah K, Delprado W, Stricker PD.

BJU Int. 2017 Dec;120(6):774-781. doi: 10.1111/bju.13814. Epub 2017 Mar 31.

20.

Computational imaging reveals shape differences between normal and malignant prostates on MRI.

Rusu M, Purysko AS, Verma S, Kiechle J, Gollamudi J, Ghose S, Herrmann K, Gulani V, Paspulati R, Ponsky L, Böhm M, Haynes AM, Moses D, Shnier R, Delprado W, Thompson J, Stricker P, Madabhushi A.

Sci Rep. 2017 Feb 1;7:41261. doi: 10.1038/srep41261.

21.

Radiomic features for prostate cancer detection on MRI differ between the transition and peripheral zones: Preliminary findings from a multi-institutional study.

Ginsburg SB, Algohary A, Pahwa S, Gulani V, Ponsky L, Aronen HJ, Boström PJ, Böhm M, Haynes AM, Brenner P, Delprado W, Thompson J, Pulbrock M, Taimen P, Villani R, Stricker P, Rastinehad AR, Jambor I, Madabhushi A.

J Magn Reson Imaging. 2017 Jul;46(1):184-193. doi: 10.1002/jmri.25562. Epub 2016 Dec 19.

22.

Histological Comparison of Kidney Tissue Following Radioembolization with Yttrium-90 Resin Microspheres and Embolization with Bland Microspheres.

de Silva S, Mackie S, Aslan P, Cade D, Delprado W.

Cardiovasc Intervent Radiol. 2016 Dec;39(12):1743-1749. Epub 2016 Oct 14.

PMID:
27743088
23.

AutoStitcher: An Automated Program for Efficient and Robust Reconstruction of Digitized Whole Histological Sections from Tissue Fragments.

Penzias G, Janowczyk A, Singanamalli A, Rusu M, Shih N, Feldman M, Stricker PD, Delprado W, Tiwari S, Böhm M, Haynes AM, Ponsky L, Viswanath S, Madabhushi A.

Sci Rep. 2016 Jul 26;6:29906. doi: 10.1038/srep29906.

24.
25.

Prospective evaluation of 68Gallium-prostate-specific membrane antigen positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer.

van Leeuwen PJ, Emmett L, Ho B, Delprado W, Ting F, Nguyen Q, Stricker PD.

BJU Int. 2017 Feb;119(2):209-215. doi: 10.1111/bju.13540. Epub 2016 Jun 18.

26.

Predicting Low-Risk Prostate Cancer from Transperineal Saturation Biopsies.

van Leeuwen PJ, Siriwardana A, Roobol M, Ting F, Nieboer D, Thompson J, Delprado W, Haynes AM, Brenner P, Stricker P.

Prostate Cancer. 2016;2016:7105678. doi: 10.1155/2016/7105678. Epub 2016 Apr 11.

27.

Colorectal carcinoma with an oncocytic component occurring in a patient with Birt-Hogg-Dubé syndrome.

Dodds T, Delprado W, Meagher A, Tucker K, Earls P.

Pathology. 2016 Apr;48(3):283-4. doi: 10.1016/j.pathol.2016.02.013. Epub 2016 Mar 9. No abstract available.

PMID:
27020508
28.

Development of Indicators to Assess Quality of Care for Prostate Cancer.

Nag N, Millar J, Davis ID, Costello S, Duthie JB, Mark S, Delprado W, Smith D, Pryor D, Galvin D, Sullivan F, Murphy ÁC, Roder D, Elsaleh H, Currow D, White C, Skala M, Moretti KL, Walker T, De Ieso P, Brooks A, Heathcote P, Frydenberg M, Thavaseelan J, Evans SM.

Eur Urol Focus. 2018 Jan;4(1):57-63. doi: 10.1016/j.euf.2016.01.016. Epub 2016 Feb 20.

PMID:
28753751
29.

Human Papilloma Virus Identification in Breast Cancer Patients with Previous Cervical Neoplasia.

Lawson JS, Glenn WK, Salyakina D, Clay R, Delprado W, Cheerala B, Tran DD, Ngan CC, Miyauchi S, Karim M, Antonsson A, Whitaker NJ.

Front Oncol. 2016 Jan 8;5:298. doi: 10.3389/fonc.2015.00298. eCollection 2015.

30.

Human Papilloma Viruses and Breast Cancer.

Lawson JS, Glenn WK, Salyakina D, Delprado W, Clay R, Antonsson A, Heng B, Miyauchi S, Tran DD, Ngan CC, Lutze-Mann L, Whitaker NJ.

Front Oncol. 2015 Dec 16;5:277. doi: 10.3389/fonc.2015.00277. eCollection 2015.

31.

Men under the age of 55 years with screen detected prostate cancer do not have less significant disease compared to older men in a population of patients in Australia.

Dantanarayana ND, Hossack T, Cozzi P, Brooks A, Lau H, Delprado W, Patel MI.

BMC Urol. 2015 Dec 30;15:124. doi: 10.1186/s12894-015-0117-3.

32.

Early Human Papilloma Virus (HPV) Oncogenic Influences in Breast Cancer.

Ngan C, Lawson JS, Clay R, Delprado W, Whitaker NJ, Glenn WK.

Breast Cancer (Auckl). 2015 Dec 10;9:93-7. doi: 10.4137/BCBCR.S35692. eCollection 2015.

33.

The Diagnostic Performance of Multiparametric Magnetic Resonance Imaging to Detect Significant Prostate Cancer.

Thompson JE, van Leeuwen PJ, Moses D, Shnier R, Brenner P, Delprado W, Pulbrook M, Böhm M, Haynes AM, Hayen A, Stricker PD.

J Urol. 2016 May;195(5):1428-1435. doi: 10.1016/j.juro.2015.10.140. Epub 2015 Oct 31.

PMID:
26529298
34.

Repeat transurethral resection for non-muscle-invasive bladder cancer: a contemporary series.

Gendy R, Delprado W, Brenner P, Brooks A, Coombes G, Cozzi P, Nash P, Patel MI.

BJU Int. 2016 Apr;117 Suppl 4:54-9. doi: 10.1111/bju.13265. Epub 2015 Oct 21.

35.

Focal irreversible electroporation for prostate cancer: functional outcomes and short-term oncological control.

Ting F, Tran M, Böhm M, Siriwardana A, Van Leeuwen PJ, Haynes AM, Delprado W, Shnier R, Stricker PD.

Prostate Cancer Prostatic Dis. 2016 Mar;19(1):46-52. doi: 10.1038/pcan.2015.47. Epub 2015 Oct 13.

PMID:
26458959
36.

Tumor volume in insignificant prostate cancer: Increasing the threshold is a safe approach to reduce over-treatment.

Ting F, van Leeuwen PJ, Delprado W, Haynes AM, Brenner P, Stricker PD.

Prostate. 2015 Nov;75(15):1768-73. doi: 10.1002/pros.23062. Epub 2015 Aug 18.

PMID:
26282713
37.

Combination of multiparametric MRI and transperineal template-guided mapping biopsy of the prostate to identify candidates for hemi-ablative focal therapy.

Tran M, Thompson J, Böhm M, Pulbrook M, Moses D, Shnier R, Brenner P, Delprado W, Haynes AM, Savdie R, Stricker PD.

BJU Int. 2016 Jan;117(1):48-54. doi: 10.1111/bju.13090. Epub 2015 May 11.

38.

Pathological evaluation and quality of surgery in radical cystectomy in New South Wales, Australia.

Ahmadi N, Delprado WJ, Brooks AJ, Brenner PC, Coombes GM, Grant A, Patel MI.

ANZ J Surg. 2015 Mar;85(3):145-9. doi: 10.1111/ans.12383. Epub 2014 Nov 19.

PMID:
25410154
39.

Extraprostatic extension (EPE) of prostatic carcinoma: is its proximity to the surgical margin or Gleason score important?

Gupta R, O'Connell R, Haynes AM, Stricker PD, Barrett W, Turner JJ, Delprado W, Horvath LG, Kench JG.

BJU Int. 2015 Sep;116(3):343-50. doi: 10.1111/bju.12911. Epub 2014 Dec 15.

40.

Teaching laparoscopic radical prostatectomy during the primary surgeon's early learning curve--analysis of our first 207 cases.

Luke S, Delprado W, Louie-Johnsun M.

BJU Int. 2014 Nov;114 Suppl 1:38-44. doi: 10.1111/bju.12799. Epub 2014 Jul 30.

41.

Lymphangioma: an unusual cause for a non-functioning adrenal mass.

Blanchard E, Brenner P, Delprado W, Samaras K.

Intern Med J. 2014 Mar;44(3):306-7. doi: 10.1111/imj.12361. No abstract available.

PMID:
24621289
42.

CD44 variant 6 is associated with prostate cancer metastasis and chemo-/radioresistance.

Ni J, Cozzi PJ, Hao JL, Beretov J, Chang L, Duan W, Shigdar S, Delprado WJ, Graham PH, Bucci J, Kearsley JH, Li Y.

Prostate. 2014 May;74(6):602-17. doi: 10.1002/pros.22775. Epub 2014 Feb 12.

PMID:
24615685
43.

Multiparametric magnetic resonance imaging guided diagnostic biopsy detects significant prostate cancer and could reduce unnecessary biopsies and over detection: a prospective study.

Thompson JE, Moses D, Shnier R, Brenner P, Delprado W, Ponsky L, Pulbrook M, Böhm M, Haynes AM, Hayen A, Stricker PD.

J Urol. 2014 Jul;192(1):67-74. doi: 10.1016/j.juro.2014.01.014. Epub 2014 Feb 8.

PMID:
24518762
44.

A multinational, multi-institutional study comparing positive surgical margin rates among 22393 open, laparoscopic, and robot-assisted radical prostatectomy patients.

Sooriakumaran P, Srivastava A, Shariat SF, Stricker PD, Ahlering T, Eden CG, Wiklund PN, Sanchez-Salas R, Mottrie A, Lee D, Neal DE, Ghavamian R, Nyirady P, Nilsson A, Carlsson S, Xylinas E, Loidl W, Seitz C, Schramek P, Roehrborn C, Cathelineau X, Skarecky D, Shaw G, Warren A, Delprado WJ, Haynes AM, Steyerberg E, Roobol MJ, Tewari AK.

Eur Urol. 2014 Sep;66(3):450-6. doi: 10.1016/j.eururo.2013.11.018. Epub 2013 Nov 24.

PMID:
24290695
45.

Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway.

Ni J, Cozzi P, Hao J, Beretov J, Chang L, Duan W, Shigdar S, Delprado W, Graham P, Bucci J, Kearsley J, Li Y.

Int J Biochem Cell Biol. 2013 Dec;45(12):2736-48. doi: 10.1016/j.biocel.2013.09.008. Epub 2013 Sep 25.

PMID:
24076216
46.

Cancer identified incidentally in the prostate following radical cystoprostatectomy: an Australian study.

Ahmadi N, Delprado WJ, Brooks AJ, Brenner PC, Coombes GM, Grant A, Patel MI.

ANZ J Surg. 2014 Jun;84(6):473-6. doi: 10.1111/ans.12015. Epub 2012 Dec 10.

PMID:
23216652
47.

Epstein-Barr virus, human papillomavirus and mouse mammary tumour virus as multiple viruses in breast cancer.

Glenn WK, Heng B, Delprado W, Iacopetta B, Whitaker NJ, Lawson JS.

PLoS One. 2012;7(11):e48788. doi: 10.1371/journal.pone.0048788. Epub 2012 Nov 19.

48.

Human papillomavirus and Epstein Barr virus in prostate cancer: Koilocytes indicate potential oncogenic influences of human papillomavirus in prostate cancer.

Whitaker NJ, Glenn WK, Sahrudin A, Orde MM, Delprado W, Lawson JS.

Prostate. 2013 Feb 15;73(3):236-41. doi: 10.1002/pros.22562. Epub 2012 Jul 31.

PMID:
22851253
49.

Accuracy of primary systematic template guided transperineal biopsy of the prostate for locating prostate cancer: a comparison with radical prostatectomy specimens.

Huo AS, Hossack T, Symons JL, PeBenito R, Delprado WJ, Brenner P, Stricker PD.

J Urol. 2012 Jun;187(6):2044-9. doi: 10.1016/j.juro.2012.01.066. Epub 2012 Apr 11.

PMID:
22498226
50.

High Gleason grade carcinoma at a positive surgical margin predicts biochemical failure after radical prostatectomy and may guide adjuvant radiotherapy.

Savdie R, Horvath LG, Benito RP, Rasiah KK, Haynes AM, Chatfield M, Stricker PD, Turner JJ, Delprado W, Henshall SM, Sutherland RL, Kench JG.

BJU Int. 2012 Jun;109(12):1794-800. doi: 10.1111/j.1464-410X.2011.10572.x. Epub 2011 Oct 12.

Supplemental Content

Loading ...
Support Center